Investor Relations

EternoGen has secured $6.8 million, which has driven product development and optimization.

The academic research was so impressive it attracted the first University of Missouri Enterprise Investment Program Awards. Over 10% of funds came from the management team. In addition, our current investors include the following organizations:

Current investors include:

logo-centennial-investors       logo-advancing-missouri

logo-arch-grants         logo-sinclair-research         logo-mtc
 

Commercialisation in Europe and Asia

EternoGen is currently seeking commercialising of RPC Pure Collagen in Europe. EternoGen’s success factors are:

  • Large and rapidly growing market
  • Clear customer and consumer need
  • Superior and unique technology
  • Experienced team
  • Attractive acquisition target

For more information

Please download our Investor information or contact us.